Decoy could halt this deadly (and spreading) virus

More viral outbreaks are likely. Researchers are working to thwart one, Venezuelan equine encephalitus virus, with a decoy molecule.

Tamara Bhandari-Washington University • futurity
Nov. 20, 2020 ~7 min

brains viruses drug-development health-and-medicine

Small molecule, big potential for treating prostate cancer

MIT researchers identify a molecule that could target advanced prostate cancer as well as a variety of other cancers.

Bendta Schroeder | Koch Institute • mit
Nov. 19, 2020 ~9 min

medicine cancer research drug-development school-of-engineering national-institutes-of-health-nih biological-engineering koch-institute

Silencing gene expression to cure complex diseases

Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.

Zach Winn | MIT News Office • mit
Oct. 26, 2020 ~9 min

health medicine genetics cancer startups biology rna alzheimers data disease research drug-development school-of-engineering innovation-and-entrepreneurship-ie alumniae biological-engineering

AI tool could predict how drugs will react in the body

Metabolic Translator, a new deep-learning tool, may offer a way to see how drugs in development will work in the body, not just the lab.

Mike Williams-Rice • futurity
Oct. 7, 2020 ~6 min

machine-learning research drug-development health-and-medicine medications

Potential drug could ‘jam’ hand, foot, and mouth disease

Targeting RNA with small molecules could pave the way for new antivirals, in particular a drug for hand, foot, and mouth disease.

Robin Smith-Duke • futurity
Sept. 24, 2020 ~6 min

rna viruses drug-development health-and-medicine


3D ‘map’ of oxytocin receptor could bring new drugs

Researchers have determined the 3D structure of the receptor that the hormone oxytocin binds to. The findings could aid drug development.

U. Zurich • futurity
Aug. 3, 2020 ~5 min

hormones oxytocin drug-development health-and-medicine


Finch Therapeutics unleashes the power of the gut

The company is developing treatments that restore gut bacteria in people struggling with a range of diseases.

Zach Winn | MIT News Office • mit
July 23, 2020 ~8 min

health medicine bacteria startups microbes microbiology research drug-development school-of-engineering alumniae biological-engineering microboime

COVID-19 vaccine is showing promise in phase 1 trial

"These interim results are very encouraging," says Evan Anderson of a COVID-19 vaccine in a phase 1 clinical trial.

Quinn Eastmann-Emory • futurity
July 20, 2020 ~5 min

covid-19 vaccines drug-development clinical-trials featured health-and-medicine immune-systems

Page 1 of 14